George Vlachogiannis, Executive Editor of Cancer Control at Sage Publishing, shared an article by Enes Ucgul on LinkedIn:
“Sarcopenia and inflammation predict poorer outcomes in cancer immunotherapy.
Monitoring muscle mass and systemic inflammation can help optimize survival strategies for cancer patients.
Paper out in Cancer Control.”
Factors Influencing Immunotherapy Outcomes in Cancer: Sarcopenia and Systemic Inflammation.
Authors: Enes Ucgul, et al.
